qRT-PCR and western blot analysis indicated that the expression of CYP1B1 and CXCR4 was significantly elevated in AML patients compared with normal controls (Figures 6(a) and 6(b)). The gene discussed is CYP1B1; the disease is acute myeloid leukemia.